Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.4 USD | +0.31% | +4.52% | -11.16% |
Financials (USD)
Sales 2024 * | 357M | Sales 2025 * | 503M | Capitalization | 4.06B |
---|---|---|---|---|---|
Net income 2024 * | -722M | Net income 2025 * | -672M | EV / Sales 2024 * | 12.9 x |
Net Debt 2024 * | 558M | Net Debt 2025 * | 616M | EV / Sales 2025 * | 9.29 x |
P/E ratio 2024 * |
-5.96
x | P/E ratio 2025 * |
-7.05
x | Employees | 912 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.78% |
Latest transcript on Insmed Incorporated
1 day | +1.11% | ||
1 week | +2.78% | ||
Current month | -1.44% | ||
1 month | -6.53% | ||
3 months | -13.65% | ||
6 months | +5.48% | ||
Current year | -11.84% |
Managers | Title | Age | Since |
---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 55 | 12-09-09 |
Sara Bonstein
DFI | Director of Finance/CFO | 43 | 20-01-30 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-12-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 20-03-31 |
Al Altomari
BRD | Director/Board Member | 65 | 12-08-01 |
Melvin Sharoky
BRD | Director/Board Member | 73 | 01-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 27.5 | +0.66% | 233 659 |
24-03-27 | 27.32 | +1.11% | 1,257,538 |
24-03-26 | 27.02 | +0.07% | 1,182,340 |
24-03-25 | 27 | +2.16% | 958,544 |
24-03-22 | 26.43 | +0.34% | 967,867 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.84% | 4.06B | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.83% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |